Literature DB >> 1641974

Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture.

A J Macadam1, G Ferguson, J Burlison, D Stone, R Skuce, J W Almond, P D Minor.   

Abstract

Part of the 5' noncoding regions of all three Sabin vaccine strains of poliovirus contains determinants of attenuation that are shown here to influence the ability of these strains to grow at elevated temperatures in BGM cells. The predicted RNA secondary structure of this region (nt 464-542 in P3/Sabin) suggests that both phenotypes are due to perturbation of base-paired stems. Ts phenotypes of site-directed mutants with defined changes in this region correlated well with predicted secondary structure stabilities. Reversal of base-pair orientation had little effect whereas stem disruption led to marked increases in temperature sensitivity. Phenotypic revertants of such viruses displayed mutations on either side of the stem. Mutations destabilizing stems led to intermediate phenotypes. These results provided evidence for the biological significance of the predicted RNA secondary structure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1641974     DOI: 10.1016/0042-6822(92)90565-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

1.  Activity of a type 1 picornavirus internal ribosomal entry site is determined by sequences within the 3' nontranslated region.

Authors:  Elena Dobrikova; Paola Florez; Shelton Bradrick; Matthias Gromeier
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-26       Impact factor: 11.205

2.  Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells.

Authors:  Stephanie A Campbell; Jennifer Lin; Elena Y Dobrikova; Matthias Gromeier
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; J Balanant; A Macadam; D Otelea; M Combiescu; A A Combiescu; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.

Authors:  Franck B Riquet; Claire Blanchard; Sophie Jegouic; Jean Balanant; Sophie Guillot; Marie-Anne Vibet; Mala Rakoto-Andrianarivelo; Francis Delpeyroux
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

Review 5.  RNA-protein interactions in regulation of picornavirus RNA translation.

Authors:  G J Belsham; N Sonenberg
Journal:  Microbiol Rev       Date:  1996-09

6.  Forced evolution of a regulatory RNA helix in the HIV-1 genome.

Authors:  B Berkhout; B Klaver; A T Das
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

7.  Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication.

Authors:  Andrew J Macadam; Geraldine Ferguson; David M Stone; Janet Meredith; Sarah Knowlson; Ghazi Auda; Jeffrey W Almond; Philip D Minor
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Biological significance of a human enterovirus B-specific RNA element in the 3' nontranslated region.

Authors:  Ingrid Merkle; Mark J M van Ooij; Frank J M van Kuppeveld; Dirk H R F Glaudemans; Jochem M D Galama; Andreas Henke; Roland Zell; Willem J G Melchers
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Characterization of recombinant dengue-2 virus derived from a single nucleotide substitution in the 5' noncoding region.

Authors:  Vijittra Leardkamolkarn; Wipawan Sirigulpanit; Richard M Kinney
Journal:  J Biomed Biotechnol       Date:  2010-03-22

10.  Recombinant oncolytic poliovirus eliminates glioma in vivo without genetic adaptation to a pathogenic phenotype.

Authors:  Elena Y Dobrikova; Trevor Broadt; Judith Poiley-Nelson; Xiaoyi Yang; Gopalan Soman; Steve Giardina; Ray Harris; Matthias Gromeier
Journal:  Mol Ther       Date:  2008-09-02       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.